Zoledronic acid medac Union européenne - islandais - EMA (European Medicines Agency)

zoledronic acid medac

medac gesellschaft für klinische spezialpräparate mbh - zoledronsýru einhýdrat - fractures, bone; cancer - lyf til að meðhöndla beinsjúkdóma - forvarnir vegna tengdra beinagrindar (sjúkdómsbrot, mænuþrýstingur, geislun eða skurðaðgerð í bein eða æxlisfrumna blóðkalsíumhækkun) hjá fullorðnum sjúklingum með langt gengið illkynja sjúkdóma sem fela í sér bein. meðferð fullorðinn sjúklinga með æxli völdum álíka (tih).

Carmustine medac (previously Carmustine Obvius) Union européenne - islandais - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - Æxlishemjandi lyf - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Bendamustine medac Stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

bendamustine medac stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - bendamustinum hýdróklóríð - stofn fyrir innrennslisþykkni, lausn - 2,5 mg/ml

Doxorubicin medac Innrennslislyf, lausn 2 mg/ml Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

doxorubicin medac innrennslislyf, lausn 2 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - doxorubicinum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml

Hydroxyurea medac Hart hylki 500 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

hydroxyurea medac hart hylki 500 mg

medac gesellschaft für klinische spezialpräparate gmbh - hydroxycarbamidum inn - hart hylki - 500 mg

Methylphenidate Medical Valley Forðatafla 27 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 27 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 27 mg

Methylphenidate Medical Valley Forðatafla 18 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 18 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Methylphenidate Medical Valley Forðatafla 36 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 36 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 36 mg

Methylphenidate Medical Valley Forðatafla 54 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 54 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 54 mg